Samsung Biologics is committed to delivering solid financial results and sustainable business leadership through the maintenance of high standards of responsibility and ethics. Effective governance is critical for us to build a collaborative environment between management and employees, fulfill our responsibilities to clients, and create long-term value for shareholders.
- 000,000KRW
- 0,000
- (0.00%)
-
Volume
000,000
-
Today's open
₩000,000
-
High
₩000,000
-
Low
₩000,000
-
Previous Close
₩000,000
Latest Quarter Results
-
Latest News
-
-
Press Releases
2026.10.16
Samsung Biologics Publishes Definitive Interim Result for PolyPeptide Tender Offer with 87.92% Participation Rate
-
Press Releases
2026.10.13
Samsung Biologics Publishes Provisional Interim Result for PolyPeptide Public Tender Offer with 87.92% Participation Rate
-
Media Focus
2026.10.13
What are the key bottlenecks preventing rapid adoption of novel technologies?
-
Media Focus
2026.10.13
Advancing bioconjugate development through platform-based analytics
-
Press Releases
2026.10.16